UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047077
Receipt number R000053475
Scientific Title A retrospective observational study of a novel smartphone App on the management of patients with mild cognitive impairment or mild dementia
Date of disclosure of the study information 2022/03/04
Last modified on 2023/03/05 18:41:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective observational study of a novel smartphone App on the management of patients with mild cognitive impairment or mild dementia

Acronym

A observational study of a novel smartphone App on patients with mild cognitive impairment or mild dementia

Scientific Title

A retrospective observational study of a novel smartphone App on the management of patients with mild cognitive impairment or mild dementia

Scientific Title:Acronym

A observational study of a novel smartphone App on patients with mild cognitive impairment or mild dementia

Region

Japan


Condition

Condition

Mild cognitive impairment/Mild dementia

Classification by specialty

Medicine in general Neurology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We aimed to conduct a retrospective observational study in patients with mild cognitive impairment/mild dementia using the LQ-M/D application to investigate the safety and efficacy of the application.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in Mini Mental State Examination (MMSE) scores before and after using the LQ-M/D application

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1. Men and women who are between 40 and 90 years old at the time of the application start
2. Diagnosed with MCI or dementia according to DSM-5
3. MMSE score of 20 or higher and CDR score of 0 to 1
4. Performance status of 0

Key exclusion criteria

1. Patients who do not wish to participate in this study by opting out
2. Using other health care applications for health promotion purposes
3. Enrolled in other clinical trials (unless they are enrolled only in observational studies without therapeutic intervention)

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Shigeo
Middle name
Last name Horie

Organization

Graduate School of Medicine, Faculty of Medicine, Juntendo University

Division name

Department of Digital Therapeutics

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-5802-1021

Email

shorie@juntendo.ac.jp


Public contact

Name of contact person

1st name Reo
Middle name
Last name Hamaguchi

Organization

Graduate School of Medicine, Faculty of Medicine, Juntendo University

Division name

Department of Digital Therapeutics

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-5802-1021

Homepage URL


Email

r.hamaguchi.ea@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Life Quest Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of the Faculty of Medicine, Juntendo University, Japan

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

03-5802-1021

Email

igakubu.rinri1@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 02 Month 04 Day

Date of IRB

2022 Year 02 Month 25 Day

Anticipated trial start date

2022 Year 03 Month 04 Day

Last follow-up date

2022 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a retrospective observational study of patients who used a smartphone application to maintain and improve cognitive function for mild cognitive impairment/mild dementia.


Management information

Registered date

2022 Year 03 Month 04 Day

Last modified on

2023 Year 03 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053475